Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Journal of the American Veterinary Medical Association|September 1, 1992
Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990)B S Kipperman, E C Feldman, N O Dybdal, et al.
Journal of Patient Safety|March 20, 2024
Medical Students' Speak-Up Barriers: A Randomized Controlled Trial With Written VignettesJesper Dybdal Kayser, Annette Kjær Ersbøll, Michaela Kolbe, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 13, 2018
Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus MonkeysRodney A Prell, Noel Dybdal, Akihiro Arima, et al.
Toxicologic Pathology|October 26, 2019
Scientific and Regulatory Policy Committee Points to Consider*: The Toxicologic Pathologist's Role in the 3RsRenee R Hukkanen, Noel Dybdal, Niraj Tripathi, et al.
Health Promotion Practice|February 22, 2019
Group Gardening in a Native American Community: A Collaborative ApproachBlakely Brown, Laura Dybdal, Curtis Noonan, et al.
Toxicologic Pathology|October 10, 2019
Ovarian Toxicity Assessment in Histopathological Images Using Deep LearningFangyao Hu, Leah Schutt, Cleopatra Kozlowski, et al.
Endocrinology|September 1, 1988
Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitaryW R Millington, N O Dybdal, R Dawson, et al.
Patient Education and Counseling|July 16, 2025
Mobile app-based pain management education for ambulatory surgery patients in Denmark: A Legitimation Code Theory analysisAnette Lykke Hindhede, Tom Moeller, Karsten Lomholt Lassen, et al.
Emergency Medicine Journal : EMJ|December 10, 2013
Is there a diurnal difference in mortality of severely injured trauma patients?Bitten Dybdal, Christian Svane, Rasmus Hesselfeldt, et al.
Regulatory Toxicology and Pharmacology : RTP|July 9, 2025
Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs - an IQ DruSafe industry surveyCleo Leung, Bart Jessen, Benno Rattel, et al.
Pageof 12